The recalled 100 mg/25 mg losartan and potassium/hydrochlorothiazide tablets contained small amounts of N-nitrosodiethylamine, or NDEA, according to a company recall notice shared on the Food and ...

Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. In a Sept. 19 statement ...

Losartan oral tablet is a generic drug prescribed to treat high blood pressure, lower stroke risk in adults with high blood pressure and left ventricular hypertrophy, and treat diabetic nephropathy.

Sandoz Inc. is voluntarily recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine (NDEA). The substance is a probable human ...

Now company officials have added an additional six lots of Losartan potassium and hydrochlorothiazide tablets after trace amounts of N-nitrosodiethylamine (NDEA) was found in one of the pill's ...

Torrent Pharmaceuticals Limited is recalling 60 lots of Losartan potassium tablets and 54 lots of Losartan potassium/ hydrochlorothiazide tablets because they contain "N-Methylnitrosobutyric (NMBA ...

Losartan potassium tablets sold by Macleods Pharmaceuticals ... The recall involves losartan and potassium/hydrochlorothiazide combination pills found to contain N-Nitroso-N-methyl-4-aminobutyric ...

Torrent Pharmaceuticals Limited said its Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, are affected by the recall. The ingredient detected was identified ...

The FDA continues to update the list of medications being recalled. The Food and Drug Administration has recently recalled a number of blood pressure medications after discovering that they ...

Torrent Pharmaceuticals Limited has once again expanded its recall of Losartan potassium tablets and Losartan potassium/hydrochlorothiazide tablets, the Food and Drug Administration announced ...

(WHDH) — The manufacturer of a number of popular blood pressure medications has expanded its recall for two products after a possible cancer-causing ingredient was found in the tablets ...